Esperion Therapeutics to Present at 34th Annual J.P. Morgan Healthcare Conference
06. Januar 2016 16:30 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density...